Search Results - "TOBITA, Tadasu"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Two cases of acute promyelocytic leukemia complicated by torsade de pointes during arsenic trioxide therapy by NAITO, Kensuke, KOBAYASHI, Miki, SAHARA, Naohi, SHIGENO, Kazuyuki, NAKAMURA, Satoki, SHINJO, Kaori, TOBITA, Tadasu, TAKESHITA, Akihiro, OHNO, Ryuzo, OHNISHI, Kazunori

    Published in International journal of hematology (01-05-2006)
    “…We describe 2 patients with acute promyelocytic leukemia (APL) in whom torsade de pointes (TdP) developed during treatment with arsenic trioxide. Patient 1 was…”
    Get full text
    Journal Article
  2. 2

    Plasma endotoxin assay by supersensitive reagent for the diagnosis of gram-negative bacteremia by Tobita, Tadasu, Ishihara, Miyako, Mihara, Toshihito

    “…With a novel supersensitive reagent, we evaluated the utility of measuring plasma endotoxin level for the rapid and sensitive diagnosis of gram-negative…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Relapse in the External Auditory Canal of Acute Promyelocytic Leukemia after Treatment with All-Trans Retinoic Acid by TOBITA, Tadasu, SHINJYO, Kaori, YANAGI, Mitsuaki, TAKESHITA, Akihiro, OHNISHI, Kazunori, OHNO, Ryuzo

    Published in Internal Medicine (1997)
    “…A 54-year-old female was admitted to our hospital for gingival bleeding and was diagnosed as acute promyelocytic leukemia (APL). She received induction therapy…”
    Get full text
    Journal Article
  5. 5

    Treatment With a New Synthetic Retinoid, Am80, of Acute Promyelocytic Leukemia Relapsed From Complete Remission Induced by All-trans Retinoic Acid by Tobita, Tadasu, Takeshita, Akihiro, Kitamura, Kunio, Ohnishi, Kazunori, Yanagi, Mitsuaki, Hiraoka, Akira, Karasuno, Takahiro, Takeuchi, Makoto, Miyawaki, Shuuichi, Ueda, Ryuzo, Naoe, Tomoki, Ohno, Ryuzo

    Published in Blood (01-08-1997)
    “…Differentiation therapy with all-trans retinoic acid (ATRA) has marked a major advance and become the first choice drug in the treatment of acute promyelocytic…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Clinicopathological and prognostic characteristics of CD33-positive multiple myeloma by Sahara, Naohi, Ohnishi, Kazunori, Ono, Takaaki, Sugimoto, Yuya, Kobayashi, Miki, Takeshita, Kaori, Shigeno, Kazuyuki, Nakamura, Satoki, Naito, Kensuke, Tamashima, Sadahiro, Nara, Kenji, Tobita, Tadasu, Takeshita, Akihiro, Ohno, Ryuzo

    Published in European journal of haematology (01-07-2006)
    “…:  There have been few reports about the CD33 expression on multiple myeloma (MM) cells so far, showing that only a few patients expressed CD33 homogenously on…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Modulation of Homeobox B6 and B9 Genes Expression in Human Leukemia Cell Lines during Myelomonocytic Differentiation by Ohnishi, Kazunori, Tobita, Tadasu, Sinjo, Kaori, Takeshita, Akihito, Ohno, Ryuzo

    Published in Leukemia & lymphoma (01-11-1998)
    “…Homeobox genes (HOX) may have a regulatory function in the differentiation process of hematopoiesis. We examined the change of HOX B6 and HOX B9 mRNA…”
    Get full text
    Journal Article
  11. 11

    New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia : clinical and basic studies for the next generation by KITAMURA, K, KIYOI, H, YOSHIDA, H, TOBITA, T, TAKESHITA, A, OHNO, R, NAOE, T

    “…All-trans retinoic acid (ATRA) is a potent differentiation drug for acute promyelocytic leukemia (APL) and is now incorporated into first-line therapy…”
    Get full text
    Conference Proceeding Journal Article
  12. 12
  13. 13

    Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid by TOBITA, T, TAKESHITA, A, NAOE, T, OHNO, R, KITAMURA, K, OHNISHI, K, YANAGI, M, HIRAOKA, A, KARASUNO, T, TAKEUCHI, M, MIYAWAKI, S, UEDA, R

    Published in Blood (01-08-1997)
    “…Differentiation therapy with all-trans retinoic acid (ATRA) has marked a major advance and become the first choice drug in the treatment of acute promyelocytic…”
    Get full text
    Journal Article
  14. 14